Our efforts to battle the Coronavirus (COVID-19)

Omega Bio-tek is assisting scientists, researchers and healthcare workers around the globe in accelerating the screening and detection of the novel coronavirus disease, COVID-19. We are supporting several Laboratory Developed Tests (LDTs) by providing high-throughput, automated viral nucleic acid extraction methodologies. To meet the exceptional and immediate need for supplies, Omega Bio-tek created a more robust kit, Mag-Bind® Viral RNA Xpress Kit, and has the capacity to support 6 million patient tests per month. Omega Bio-tek is working alongside scientists in providing extraction technologies to expert technical and automation support in quickly establishing pathogen detection workflows to curtail the escalating spread of COVID-19.  

High Throughput Viral Nucleic Acid Extraction

High quality extraction of SARS-CoV-2 RNA

Mag-Bind® Viral RNA Xpress Kit

  • Isolation of viral RNA from swabs in viral transport media
  • Fully automatable and ready-to-load scripts for:
    – KingFisher™, BioSprint®, and MagMAX® 96:  96 samples
    – Hamilton MagEx STARlet:  96 samples in ~1 hr 45 min.
    – Hamilton Microlab® STAR™: (4×96) 384 samples in ~3 hr
    – Hamilton Microlab VANTAGE®: (4X96) 384 samples in ~75 min
    – Tecan Fluent® Automated Workstation 1080:
    (4×96) 384 samples ~75 min
  • Adaptable to other liquid handling platforms
  • Dedicated technical and application support to expedite setup and validation time
  • No backorder
  • Same or next-day shipping in the US and EU

16 Laboratories

were granted Emergency Use Authorization (EUA)

by the U.S. Food and Drug Administration (FDA) utilizing our viral RNA extraction kits, including QUEST DIAGNOSTICS.


for COVID-19 testing.

With the new Mag-Bind Viral RNA Xpress Kit, Omega Bio-tek is able to deliver a robust and reliable extraction product and triple production capacity to produce up to 6 million tests per month.

OVER 26000000 

Viral RNA extractions shipped for COVID-19 testing.

Omega Bio-tek is committed to supporting laboratories and researchers worldwide to combat COVID-19. Reach out to one of our sales representatives today.

Detection of Synthetic SARS-CoV-2 virus control following RT-qPCR

Figure 1. 1×105 copies of synthetic SARSCoV-2 was spiked into a 200 μL sample containing 2000 HEK293 cells. Viral nucleic acids were extracted following the recommended protocol from Mag-Bind® Viral RNA Xpress Kit (M6219). 4 and 8 μL of template was used in a 20 μL SYBR Greenlabeled RT-qPCR reaction. The average Ct values obtained are shown on the left. The Ct difference between the two template 30.89 amounts is ~1 indicating no qPCR inhibition.

Patients Choice Laboratories Finds COVID-19 Testing Solutions During the Pandemic with Omega Bio-tek’s Viral RNA Extraction Kit.
Read how Omega Bio-tek helped Patients Choice Laboratories overcome viral RNA extraction kit shortages for COVID-19 testing and helped them gain their Emergency Use Authorization (EUA) from the FDA.

Saliva as a Diagnostic Tool for COVID-19

A Proof-of-Concept Study

A comprehensive extraction-based workflow from collection to detection

To combat a fast-evolving global pandemic like COVID-19, it is essential to develop rapid and accurate diagnostic tests with a quick turnaround time. Recently, saliva has emerged as a viable alternate sample source to nasopharyngeal swabs and has shown to have greater detection sensitivity of SARS-CoV-2, as well as consistency throughout the course of infection. Saliva collection is non-invasive, can be self-administered in the convenience of one’s home eliminating the exposure risk to healthcare workers, and reduces the overall burden on swab and personal protective equipment supplies.